The Past, Present and Future of HIV Funding

By Juliet Glassroth December 11, 2017

This article was published on The American Journal of Managed Care’s website on December 11, 2017.

A Kaiser Family Foundation web briefing navigated the HIV/AIDS funding landscape, taking a look at trends over time, the latest data, and what we might expect in the future.

When analyzing federal funding by the US government for HIV both home and abroad since the first AIDS cases were identified in 1981, “you notice a very dramatic, steep rise at different points, and generally a rise over time,” said Jen Kates, vice president, director of global health and HIV policy, Kaiser Family Foundation.

The trend can be attributed to a couple of factors, said Kates. While the political well plays a role, there are 2 factors that really account for the rise in spending: the increasing number of people living with HIV in the US, which has led to increasing expenditures on care and treatment; the other is the increasing recognition of the importance of combatting the global epidemic.The current federal budget for HIV funding is $32.9 billion. Accounting for the largest proportion of the total cost is care and treatment (60%); global funding accounts for 20%, cash and housing assistance accounts for 9%, research accounts for 8%, and prevention accounts for 3%.

The article in its entirety is available here.